Toyota Motor Corp faced scrutiny from the US Congress over its biggest ever safety recall as investors and consumers weighed the impact of an unprecedented halt in US production by the No. 1 automaker.
US House Energy and Commerce Committee Chairman Henry Waxman said he would hold a hearing next month to consider “how quickly and effectively” the car maker responded to complaints about unintended and dangerous acceleration.
“Like many consumers, I am concerned by the seriousness and scope of Toyota’s recent recall announcements,” Waxman said in a statement.
The unusual action by the US government came just hours after the Toyota recall for accelerator problems was widened to include China and Europe.
Toyota this week suspended North American sales and production of eight models — including its best-selling Camry after pressure from regulators.
The world’s largest automaker and a company studied for its devotion to quality, Toyota has recalled about 8 million vehicles in recent months — more than the number of cars and trucks it sold worldwide last year.
Analysts said the financial impact would depend on how long the safety problems shut production and whether Toyota’s famously loyal customers begin to abandon the brand, an issue hotly debated on blogs and online forums.
Shares of Toyota have dropped 17.6 percent since Jan. 21, when it announced it was broadening its recalls by a further 2.3 million vehicles. The stock ended down 2 percent in Tokyo yesterday.
Industry analysts and executives estimated it would cost about US$250 million in warranty costs alone to address the smaller of the two recalls under way in the US.
The automaker also faces the fallout from the larger recall that began last year and was broadened this week for vehicles at risk of having floormats that can become jammed under accelerator pedals.
Meanwhile, Toyota said it was racing to fix one of the recurring problems with sticky accelerator pedals that has forced it to shut down sales and production of most vehicles in the US.
In consultations with its dealers on Thursday, Toyota said it would take months to complete repairs on the recalled vehicles since it would send notices to affected customers in batches of ten thousand to avoid overrunning repair shops.
CTS Corp, the manufacturer of the accelerator pedals that led to the sales half, said on Thursday that it has completed work on a redesigned accelerator pedal and was rushing that fixed part into production for Toyota.
Cars sold in Japan use accelerators supplied by Denso Corp. Toyota representatives said it was not clear if Denso could supply enough accelerators to help meet the demand surge caused by the US recall. Denso said it was still reviewing the situation and declined further comment.
Taiwanese actress Barbie Hsu (徐熙媛) has died of pneumonia at the age of 48 while on a trip to Japan, where she contracted influenza during the Lunar New Year holiday, her sister confirmed today through an agent. "Our whole family came to Japan for a trip, and my dearest and most kindhearted sister Barbie Hsu died of influenza-induced pneumonia and unfortunately left us," Hsu's sister and talk show hostess Dee Hsu (徐熙娣) said. "I was grateful to be her sister in this life and that we got to care for and spend time with each other. I will always be grateful to
REMINDER: Of the 6.78 million doses of flu vaccine Taiwan purchased for this flu season, about 200,000 are still available, an official said, following Big S’ death As news broke of the death of Taiwanese actress and singer Barbie Hsu (徐熙媛), also known as Big S (大S), from severe flu complications, the Centers for Disease Control (CDC) and doctors yesterday urged people at high risk to get vaccinated and be alert to signs of severe illness. Hsu’s family yesterday confirmed that the actress died on a family holiday in Japan due to pneumonia during the Lunar New Year holiday. CDC Deputy Director-General Tseng Shu-hui (曾淑慧) told an impromptu news conference that hospital visits for flu-like illnesses from Jan. 19 to Jan. 25 reached 162,352 — the highest
TAIWAN DEFENSE: The initiative would involve integrating various systems in a fast-paced manner through the use of common software to obstruct a Chinese invasion The first tranche of the US Navy’s “Replicator” initiative aimed at obstructing a Chinese invasion of Taiwan would be ready by August, a US Naval Institute (USNI) News report on Tuesday said. The initiative is part of a larger defense strategy for Taiwan, and would involve launching thousands of uncrewed submarines, surface vessels and aerial vehicles around Taiwan to buy the nation and its partners time to assemble a response. The plan was first made public by the Washington Post in June last year, when it cited comments by US Indo-Pacific Commander Admiral Samuel Paparo on the sidelines of the Shangri-La Dialogue
COMBINING FORCES: The 66th Marine Brigade would support the 202nd Military Police Command in its defense of Taipei against ‘decapitation strikes,’ a source said The Marine Corps has deployed more than 100 soldiers and officers of the 66th Marine Brigade to Taipei International Airport (Songshan airport) as part of an effort to bolster defenses around the capital, a source with knowledge of the matter said yesterday. Two weeks ago, a military source said that the Ministry of National Defense ordered the Marine Corps to increase soldier deployments in the Taipei area. The 66th Marine Brigade has been tasked with protecting key areas in Taipei, with the 202nd Military Police Command also continuing to defend the capital. That came after a 2017 decision by the ministry to station